GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SD Biosensor 137310.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

6,650

+1.37%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩710.58bn

FY2019FY2025

Net income

−₩512.11bn

FY2019FY2025

Free cash flow

₩300.03bn

FY2019FY2025

Shareholders' equity

₩2.33trn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₩710.58bn₩694.57bn₩655.68bn₩2.93trn₩2.93trn₩1.69trn₩72.96bn
Gross profit₩325.53bn₩339.39bn₩126.00bn₩1.39trn₩1.57trn₩858.16bn₩20.81bn
Research and development₩78.05bn₩87.95bn₩64.20bn₩45.76bn₩18.89bn₩10.39bn₩4.87bn
Operating income—−₩54.06bn—₩1.15trn₩1.36trn₩738.26bn₩2.36bn
Net income−₩512.11bn−₩98.41bn−₩467.71bn₩911.36bn₩1.06trn₩615.64bn₩3.15bn
Diluted earnings per share-4,281.14-804.36-3,822.818,912.7810,361.646,597.2133.79

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₩3.24trn₩3.89trn₩3.79trn₩3.26trn₩3.01trn₩1.46trn₩169.72bn
Total liabilities₩905.85bn₩956.18bn₩957.28bn₩315.14bn₩801.72bn₩704.10bn₩31.80bn
Debt₩346.85bn₩586.30bn₩461.83bn₩147.4m₩274.9m—₩2.04bn
Shareholders' equity₩2.33trn₩2.92trn₩2.82trn₩2.94trn₩2.19trn₩748.02bn₩133.40bn
Shares outstanding120m122m122m102m103m93m93m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₩357.52bn₩156.53bn−₩242.32bn₩890.23bn₩1.23trn₩495.38bn−₩1.62bn
Capital spending−₩57.49bn−₩80.90bn−₩144.69bn−₩300.45bn−₩190.05bn−₩54.90bn−₩7.45bn
Free cash flow₩300.03bn₩75.62bn−₩387.01bn₩589.78bn₩1.04trn₩440.48bn−₩9.08bn
Dividends paid−₩24.18bn−₩38.1m−₩29.55bn−₩198.74bn−₩49.83bn−₩49.83bn−₩49.83bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩186.48bn₩193.53bn₩194.57bn₩164.19bn₩166.50bn₩185.33bn₩180.12bn₩170.61bn
Gross profit₩92.55bn₩100.72bn₩72.63bn₩80.10bn₩79.41bn₩93.38bn₩87.39bn₩82.09bn
Operating income₩16.71bn₩25.51bn—−₩13.97bn—−₩12.38bn−₩18.07bn—
Net income₩16.46bn₩22.70bn−₩758.94bn−₩9.72bn₩275.23bn−₩18.67bn−₩133.62bn₩65.07bn
Diluted earnings per share137.64189.81-6,344.64-81.252,300.87-156.11-1,107.80531.82
Cash from operations₩1.55bn−₩4.14bn₩44.44bn₩14.89bn₩314.89bn−₩16.71bn−₩17.34bn₩134.85bn
Capital spending−₩9.03bn−₩11.80bn−₩12.55bn−₩12.64bn−₩17.96bn−₩14.34bn−₩15.96bn−₩25.22bn
Free cash flow−₩7.48bn−₩15.94bn₩31.88bn₩2.26bn₩296.94bn−₩31.05bn−₩33.29bn₩109.64bn
Total assets₩2.90trn₩2.95trn₩3.24trn₩3.98trn₩3.92trn₩3.84trn₩3.89trn₩3.77trn
Debt₩266.68bn₩291.81bn₩346.85bn₩605.01bn₩571.08bn₩606.52bn₩586.30bn₩503.59bn
Shareholders' equity₩2.40trn₩2.37trn₩2.33trn₩3.06trn₩3.02trn₩2.87trn₩2.92trn₩2.90trn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-41.0%-18.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin47.3%43.7%48.0%—
Net margin-43.4%-3.3%15.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-2.1-12.8-3.03.45.4
Price to sales1.82.02.31.12.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2023FY2022
Paid in the year200.00200.00290.001,966.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.